BioNxt Solutions Inc. (CVE:BNXT) | WebDisclosure

Basculer en Français

10370	Companies
216135	Keywords
145860	Articles
114450	Press releases

Headlines Articles Press releases BioNxt Solutions Inc.

Home
Companies
BioNxt Solutions Inc.

PRESS RELEASE

published on 02/27/2026 at 01:00, 2 months 9 days ago

BioNxt Announces Closing of Shares for Debt Settlement
BioNxt Solutions Inc. settles $2.7M debt with 6,008,883 common shares. Compensation shares issued to Canaccord Genuity Corp. for facilitating the debt settlement. Company focuses on drug delivery tech and pharmaceutical development

Common Shares Debt Settlement BioNxt Solutions Inc. Drug Delivery Pharmaceutical Development
BRIEF

published on 02/17/2026 at 09:10, 2 months 19 days ago

BioNxt obtient un brevet européen pour sa technologie de cladribine sublinguale

Sclérose En Plaques Solutions BioNxt Brevet Européen Administration De Médicaments Technologie Sublinguale
BRIEF

published on 02/17/2026 at 09:10, 2 months 19 days ago

BioNxt Secures European Patent for Sublingual Cladribine Technology

Multiple Sclerosis Drug Delivery European Patent BioNxt Solutions Sublingual Technology
PRESS RELEASE

published on 02/17/2026 at 09:05, 2 months 19 days ago

BioNxt Receives Milestone EPO Decision to Grant European Patent for Sublingual Cladribine Drug Delivery Technology for Multiple Sclerosis
BioNxt Solutions Inc. receives European Patent No. 4539857 for sublingual cladribine oral thin film drug delivery tech, advancing global IP rights in pharmaceutical sector

Pharmaceutical BioNxt Solutions Inc. Cladribine Drug Delivery European Patent
BRIEF

published on 02/05/2026 at 09:10, 3 months 3 days ago

BioNxt Solutions Secures Chaperone Technology to Advance Oral Drug Delivery

Drug Delivery BioNxt Solutions Neurological Diseases Chaperone Technology Oral Dissolvable Films
BRIEF

published on 02/05/2026 at 09:10, 3 months 3 days ago

BioNxt Solutions acquiert une technologie chaperonne pour faire progresser l'administration orale de médicaments

Solutions BioNxt Administration De Médicaments Maladies Neurologiques Technologie Des Chaperons Films Orodispersibles
PRESS RELEASE

published on 02/05/2026 at 09:05, 3 months 3 days ago

BioNxt Secures Innovative Chaperone Technology to Enhance Oral Thin-Film Drug Delivery
BioNxt Solutions Inc. announced signing a letter of intent for exclusive rights to advanced drug chaperone technology, enhancing its oral dissolvable thin-film platform

BioNxt Solutions Inc. Letter Of Intent Drug Chaperone Technology Oral Dissolvable Thin-film Biotechnology Developer
BRIEF

published on 01/26/2026 at 09:10, 3 months 13 days ago

BioNxt Advances Cladribine ODF for Multiple Sclerosis and Myasthenia Gravis

Multiple Sclerosis Drug Delivery Cladribine ODF Myasthenia Gravis BioNxt
BRIEF

published on 01/26/2026 at 09:10, 3 months 13 days ago

BioNxt fait progresser la cladribine ODF pour la sclérose en plaques et la myasthénie grave

Sclérose En Plaques Cladribine ODF Myasthénie Grave Administration De Médicaments BioNxt
PRESS RELEASE

published on 01/26/2026 at 09:05, 3 months 13 days ago

BioNxt Accelerates ODF for Multiple Sclerosis Toward Human Clinical Study with >40% Bioavailability Improvement and Myasthenia Gravis Expansion
BioNxt announces progress in cladribine oral thin film development, with focus on bioavailability improvement and human clinical study for Multiple Sclerosis. Expansion into Myasthenia Gravis also planned

Multiple Sclerosis Cladribine Myasthenia Gravis BioNxt Oral Thin Film

Accesswire

Published on 05/08/2026 at 15:55, 4 hours 36 minutes ago

Class 1 Nickel and Technologies Ltd. Announces Private Placement and Share for Debt Offering
Published on 05/08/2026 at 15:00, 5 hours 31 minutes ago

Jaguar Health Regains Compliance with Nasdaq's Publicly Held Shares Requirement and Receives Additional Extension, Until May 18, 2026, to Demonstrate Compliance with Nasdaq's Bid Price Rule
Published on 05/08/2026 at 14:55, 5 hours 36 minutes ago

Nepra Foods Inc. to Present at the 16th Annual LD Micro Invitational
Published on 05/08/2026 at 14:30, 6 hours 1 minute ago

Unusual Machines Hosts Live Drone Ecosystem Demonstrations at XPONENTIAL 2026
Published on 05/08/2026 at 14:00, 6 hours 31 minutes ago

BlackBerry Announces Renewal of Normal Course Issuer Bid Share Buyback Program

View all ACCESSWIRE

EQS Group

Published on 05/08/2026 at 19:12, 1 hour 18 minutes ago

EQS-Adhoc: Viromed Medical AG missed revenue forecast for 2025 financial year, but continued to grow significantly and achieved a positive result; revised forecast for 2026
Published on 05/08/2026 at 19:02, 1 hour 29 minutes ago

Metall Zug – Annual General Meeting of Shareholders approves all proposals
Published on 05/08/2026 at 18:29, 2 hours 2 minutes ago

Designated Person Notification
Published on 05/08/2026 at 18:29, 2 hours 2 minutes ago

Designated Person Notification
Published on 05/08/2026 at 18:21, 2 hours 10 minutes ago

Bond Issue

Les Echos

Published on 05/07/2026 at 19:15, 1 day 1 hour ago

2026 Annual General Meeting: approval of all resolutions submitted to the Meeting
Published on 05/07/2026 at 19:15, 1 day 1 hour ago

Assemblée Générale annuelle 2026 : approbation de l’ensemble des résolutions soumises au vote
Published on 05/07/2026 at 19:06, 1 day 1 hour ago

Disclosure of Share Capital and Voting Rights as of April 30, 2026
Published on 05/07/2026 at 19:06, 1 day 1 hour ago

Déclaration du nombre d’actions et droits de vote au 30 avril 2026
Published on 05/07/2026 at 19:00, 1 day 1 hour ago

ALTAREIT - INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL

View all LES ECHOS COMFI WIRE